SCHEMBL30429242

SCHEMBL30429242

CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](N)CO)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)O)C(C)C)[C@@H](C)O

nearest known ligand 0.66

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ CALCR P30988 5/20 0.63
▸ HCRTR1 O43613 1/20 0.56
▸ HCRTR2 O43614 1/20 0.56
▸ EP300 Q09472 1/20 0.56
▸ HIF1A Q16665 1/20 0.56
▸ F2 P00734 4/20 0.56
▸ CRHR1 P34998 1/20 0.55
▸ CRHR2 Q13324 1/20 0.55
▸ NPY2R P49146 7/20 0.55
▸ NPY4R P50391 7/20 0.55
▸ NPY5R Q15761 7/20 0.55
▸ NPY1R P25929 5/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30607374 0.92 CALCR (0.58) CALCRHCRTR1HCRTR2EP300HIF1A
SCHEMBL30712939 0.91 EP300 (0.67) CALCRHCRTR1HCRTR2EP300HIF1A
SCHEMBL31000946 0.91 CALCR (0.64) CALCRHCRTR1HCRTR2EP300HIF1A
SCHEMBL30726592 0.90 CALCR (0.62) CALCRHCRTR1HCRTR2EP300HIF1A
SCHEMBL30906353 0.90 CALCR (0.59) CALCREP300HIF1AF2NPY2R
SCHEMBL30277935 0.90 CALCR (0.61) CALCRHCRTR1HCRTR2EP300HIF1A
SCHEMBL30712880 0.89 CALCR (0.61) CALCRHCRTR1HCRTR2EP300HIF1A
SCHEMBL30567772 0.89 CALCR (0.74) CALCRHCRTR1HCRTR2F2CRHR1
SCHEMBL30277946 0.89 CALCR (0.60) CALCREP300HIF1A
SCHEMBL30887979 0.88 CALCR (0.65) CALCREP300HIF1ACRHR1CRHR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230165951-A1 Engineering, production and characterization of plant produced Nucleocapsid and Spike structural proteins of SARS CoV 2 as vaccine candidates against COVID19 MAMEDOV TARLAN (TR) 2023-06-01 — — US disclosed
Send feedback